Toralgen
Michael Arul is a Formulation Scientist at Toralgen since January 2023, specializing in designing and executing polymeric nanoparticles for diabetic applications utilizing peptides, proteins, and monoclonal antibodies. Previously, Michael served as an Instructor and Postdoctoral Researcher at UConn Health from May 2016 to January 2023. Prior experience includes a role as a Senior Researcher at the Central Salt & Marine Chemicals Research Institute between July 2015 and March 2016, and as a Quality Assurance Specialist at MRF Tyres Private Limited from July 2004 to May 2005. Michael holds a Postdoctoral degree from The University of Connecticut Health Center and a Doctor of Philosophy in Biomaterials for Drug Delivery from Central Salt and Marine Chemicals Research Institute, earned between 2009 and 2015.
This person is not in any offices
Toralgen
Toralgen is a is a preclinical stage biopharmaceutical company that specializes in the development and commercialization of human therapeutics. They eliminates the challenges of oral delivery in one simple-to-fabricate nanopill. These nanopills also localize the delivery of drug agents and improve the efficacy and safety of therapies.